Impairment of energy metabolism in intact residual myocardium of rat hearts with chronic myocardial infarction

S Neubauer, M Horn, A Naumann, R Tian, K Hu, M Laser, J Friedrich, P Gaudron, K Schnackerz, J S Ingwall, S Neubauer, M Horn, A Naumann, R Tian, K Hu, M Laser, J Friedrich, P Gaudron, K Schnackerz, J S Ingwall

Abstract

The purpose of this study was to test the hypothesis that energy metabolism is impaired in residual intact myocardium of chronically infarcted rat heart, contributing to contractile dysfunction. Myocardial infarction (MI) was induced in rats by coronary artery ligation. Hearts were isolated 8 wk later and buffer-perfused isovolumically. MI hearts showed reduced left ventricular developed pressure, but oxygen consumption was unchanged. High-energy phosphate contents were measured chemically and by 31P-NMR spectroscopy. In residual intact left ventricular tissue, ATP was unchanged after MI, while creatine phosphate was reduced by 31%. Total creatine kinase (CK) activity was reduced by 17%, the fetal CK isoenzymes BB and MB increased, while the "adult" mitochondrial CK isoenzyme activity decreased by 44%. Total creatine content decreased by 35%. Phosphoryl exchange between ATP and creatine phosphate, measured by 31P-NMR magnetization transfer, fell by 50% in MI hearts. Thus, energy reserve is substantially impaired in residual intact myocardium of chronically infarcted rats. Because phosphoryl exchange was still five times higher than ATP synthesis rates calculated from oxygen consumption, phosphoryl transfer via CK may not limit baseline contractile performance 2 mo after MI. In contrast, when MI hearts were subjected to acute stress (hypoxia), mechanical recovery during reoxygenation was impaired, suggesting that reduced energy reserve contributes to increased susceptibility of MI hearts to acute metabolic stress.

References

    1. Am J Physiol. 1967 Apr;212(4):804-14
    1. J Lab Clin Med. 1967 Apr;69(4):696-705
    1. Anal Biochem. 1973 Dec;56(2):341-5
    1. Methods Enzymol. 1975;41:47-52
    1. Anal Biochem. 1976 Dec;76(2):561-7
    1. Circ Res. 1979 Apr;44(4):503-12
    1. J Biol Chem. 1979 Jul 25;254(14):6528-37
    1. Basic Res Cardiol. 1982 Jul-Aug;77(4):349-58
    1. Basic Res Cardiol. 1982 Jul-Aug;77(4):359-7
    1. Proc Soc Exp Biol Med. 1984 Jan;175(1):5-9
    1. J Biol Chem. 1985 Mar 25;260(6):3512-7
    1. Am J Physiol. 1985 Jul;249(1 Pt 2):H80-7
    1. Mol Cell Biochem. 1985 Jul;67(2):151-9
    1. N Engl J Med. 1985 Oct 24;313(17):1050-4
    1. Circ Res. 1986 Jan;58(1):26-37
    1. Circ Res. 1986 Dec;59(6):597-604
    1. Circ Res. 1988 Apr;62(4):641-50
    1. Circ Res. 1988 Apr;62(4):766-75
    1. Circ Res. 1988 Jul;63(1):1-15
    1. J Neurosci Res. 1988 Sep;21(1):25-34
    1. J Mol Cell Cardiol. 1989 Nov;21(11):1163-78
    1. Eur Heart J. 1990 Apr;11 Suppl B:108-15
    1. Eur Heart J. 1990 Apr;11 Suppl B:116-22
    1. J Cardiovasc Pharmacol. 1990 Jul;16(1):1-8
    1. J Mol Cell Cardiol. 1990 Nov;22(11):1231-43
    1. Biochemistry. 1991 Mar 12;30(10):2585-93
    1. Am J Physiol. 1991 May;260(5 Pt 2):H1406-14
    1. J Cardiovasc Pharmacol. 1991 Apr;17(4):634-40
    1. Circulation. 1991 Jul;84(1):333-40
    1. Circ Res. 1992 Mar;70(3):516-29
    1. Circ Res. 1992 Oct;71(4):797-807
    1. Circulation. 1993 Jan;87(1):59-69
    1. Am Heart J. 1993 May;125(5 Pt 1):1226-33
    1. J Biol Chem. 1951 Nov;193(1):265-75
    1. Cell. 1993 Aug 27;74(4):621-31
    1. J Mol Cell Cardiol. 1993 Sep;25(9):995-1013
    1. Circulation. 1994 Feb;89(2):810-7
    1. Cardiovasc Res. 1972 May;6(3):284-94

Source: PubMed

3
Abonner